XML 43 R28.htm IDEA: XBRL DOCUMENT v3.21.2

Business Segment Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Summary of Operating Segment and Asset Information

The following table summarizes operating segment information for the three and nine months ended September 30, 2021 and 2020, and asset information as of September 30, 2021 and December 31, 2020:

		Three Months Ended September 30,								Nine Months Ended September 30,
		2021				2020				2021				2020
Net revenues:
Diagnostics		$	23,511			$	16,314			$	57,368			$	44,533
Molecular Solutions			30,406				31,697				112,738				64,333
Total		$	53,917			$	48,011			$	170,106			$	108,866
Operating income (loss):
Diagnostics		$	(18,638	)		$	(9,951	)		$	(42,755	)		$	(31,116	)
Molecular Solutions			5,625				14,336				41,962				18,054
Total		$	(13,013	)		$	4,385			$	(793	)		$	(13,062	)
Depreciation and amortization:
Diagnostics		$	1,136			$	934			$	2,965			$	2,448
Molecular Solutions			2,199				1,517				5,514				4,432
Total		$	3,335			$	2,451			$	8,479			$	6,880
Capital expenditures:
Diagnostics		$	3,647			$	2,186			$	19,797			$	5,634
Molecular Solutions			932				3,011				7,711				5,600
Total		$	4,579			$	5,197			$	27,508			$	11,234

		September 30, 2021				December 31, 2020
Total assets:
Diagnostics		$	206,668			$	242,613
Molecular Solutions			249,089				211,859
Total		$	455,757			$	454,472

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration